Biocryst Pharmaceuticals Inc (BCRX)
P/OCF Ratio
5.50×
TTM · Retrieved:
BCRX P/OCF Ratio
Current (TTM)5.50×retrieved
Current (TTM)5.50×retrieved
BCRX Quarterly P/OCF Ratio (-23.71× → 24.39×)
Latest values, visible window
High-resolution chart · PNG
BCRX p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| 24.3891× | |
| -37.1169× | |
| 5.9614× | |
| 38.3249× | |
| 45.4528× | |
| -56.9326× | |
| -299.1569× | |
| 190.719× | |
| -1,006.4728× | |
| -19.3842× | |
| -135.2814× | |
| -67.4815× | |
| -70.766× | |
| -33.0899× | |
| -89.9771× | |
| -72.3051× | |
| -70.1094× | |
| -38.6432× | |
| -77.591× | |
| -110.5754× | |
| -110.8255× | |
| -29.5615× | |
| -29.4766× | |
| -15.8733× | |
| -24.7759× | |
| -13.2431× | |
| -43.3571× | |
| -11.4663× | |
| -16.7076× | |
| -33.9911× | |
| -36.944× | |
| -21.9353× | |
| -40.7376× | |
| -23.9294× | |
| -45.9315× | |
| -35.2298× | |
| -46.2526× | |
| -74.0475× | |
| -79.7619× | |
| -18.5196× | |
| -18.7137× | |
| -11.0546× | |
| -51.0467× | |
| -65.9705× | |
| 59.9262× | |
| -175.3192× | |
| -62.916× | |
| -81.6528× | |
| -114.2635× | |
| -70.3708× | |
| -99.4666× | |
| -52.4947× | |
| -29.7352× | |
| -6.294× | |
| -10.2779× | |
| -18.5403× | |
| -30.8098× | |
| -18.5759× | |
| -28.0646× | |
| -11.9105× | |
| -49.6468× | |
| -11.9007× | |
| -39.9094× | |
| -24.0276× | |
| -31.6259× | |
| -55.6259× | |
| 29.4489× | |
| -61.8241× | |
| -13.2049× | |
| -9.2347× | |
| -11.5113× | |
| -20.2701× | |
| -18.0436× | |
| -38.9807× | |
| -14.6776× | |
| -53.6459× | |
| -265.9843× | |
| -72.1293× | |
| -22.7229× | |
| -28.0069× | |
| -30.5908× | |
| 19.836× | |
| -84.2514× | |
| -41.7398× | |
| -22.4576× | |
| -19.6656× | |
| -25.2059× | |
| -28.6492× | |
| -32.0645× | |
| -38.7655× | |
| -49.5828× | |
| -38.8977× | |
| -22.9249× | |
| -10.1045× | |
| -7.5339× | |
| -6.3504× | |
| -3.5572× | |
| -12.9846× | |
| -21.2415× | |
| -28.1619× |